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Abstract Long-lasting recovery of renal function of the
native kidneys after prolonged renal replacement therapy
is rare. An 8-year-old girl and a 3-year-old boy had
suffered from acute atypical and diarrhea-associated
hemolytic uremic syndrome (HUS), respectively, with
subsequent apparent end-stage renal failure. Both recov-
ered renal function after long-lasting anuria and dialysis
of 8 and 16 months, respectively. After prolonged follow-
up, i.e., 7 and 5 years after cessation of dialysis, they
attained normal or slightly reduced renal function (plasma
creatinine 84 and 90 mol/l, respectively). In addition,
growth and cognitive development were normal. We
conclude that caution is appropriate before offering early
renal transplantation to pediatric patients with presumed
end-stage kidney disease secondary to HUS.
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Introduction
The term end-stage kidney disease is used to indicate
irreversible kidney failure requiring dialysis and renal
transplantation. Recovery of renal function of the native
or transplanted kidneys after prolonged dialysis has rarely
been reported, and mainly in adult patients [1, 2, 3, 4, 5, 6,
7, 8, 9, 10]. We report on two children with hemolytic
uremic syndrome (HUS) [11] who experienced a long-
lasting recovery of renal function after being on dialysis
for 8 and 16 months, respectively.
Case reports
Between 1970 and 2002, 130 and 67 patients underwent chronic
renal replacement (i.e., necessary renal replacement therapy for
more than 6 months) in Zurich and Bern, respectively. In both
centers, HUS was an important cause of end-stage renal failure: 12
patients (9%) from Zurich had HUS, two had diarrhea-related HUS
and 10 atypical HUS. In Bern, HUS was the underlying cause in
five (7%) patients, one had diarrhea-related HUS and four atypical
HUS. Two of the 197 patients, both with HUS, recovered renal
function.
Case 1
An 8-year-old girl with a history of vomiting, fever and pallor for
10 days was referred. There was no history of diarrhea. Physical
examination revealed high blood pressure (132/102 mmHg: 95th
centile for gender, age and height: 115/75), pallor and a mild scleral
jaundice. Hematology showed anemia (hemoglobin 37 g/l, normal
100–150 g/l) and thrombocytopenia (85109/l, normal 200–
400109/l); a blood film demonstrated moderate red blood cell
fragmentation. Blood chemistry disclosed renal failure with
elevated creatinine (399 mol/l, normal range for age <66 mol/l)
and urea (54 mmol/l, normal <8.2 mmol/l), hyperbilirubinemia
(45 mol/l, normal <30 mol/l) and high lactate dehydrogenase
(1,360 U/l, normal <500 U/l). Complement C3, factor H and von
Willebrand cleavage protease were normal, antinuclear or antineu-
trophil cytoplasmic autoantibodies were not detected and the direct
Coombs test was negative. Specific Escherichia coli lipopolysac-
charide antibodies were not measured. Urinalysis showed hema-
turia, red cell casts and marked proteinuria. No E. coli strains
harboring genes for shigatoxin were cultured from the stool. Hence
the diagnosis of atypical (diarrhea-negative) HUS was made. A
renal biopsy was not done. Within 10 days, the girl became anuric.
Continuous automated peritoneal dialysis was started, amlodipine
was given to treat hypertension and fresh frozen plasma was
administered on 15 occasions. During the following 4 weeks she
experienced focal seizures with a tendency towards generalization.
Intravenous diazepam and phenytoin were given repeatedly,
followed by oral carbamazepine. One month after onset of the
disease the girl was switched from peritoneal dialysis to hemodi-
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alysis (three sessions per week) because of two episodes of
bacterial peritonitis. She continued to be anuric.
Six months after starting dialysis, the girl reported to pass small
portions of urine one to two times a week. One month later, urine
production increased and hemodialysis was reduced to two weekly
sessions. Eight months after onset, dialysis was finally stopped. The
subsequent clinical course was uneventful.
Recently, i.e., 7 years after cessation of dialysis, the girl was
well on treatment with irbesartan 300 mg daily, chlorthalidone
25 mg daily, and carabamazepine 1,200 mg daily. Growth (body
weight: 52 kg, height: 1.64 m) and cognitive development were
both normal. Renal function, as assessed as plasma creatinine
(84 mol/l, normal range for age <98 mol/l) and estimated
glomerular filtration rate (Schwartz formula: 78 ml/min/1.73 m2
body surface area), was normal. In addition, casual blood pressure
(109/50 mmHg: 95th centile: 128/83 mmHg) and 24-h ambulatory
blood pressure (108/62 mmHg: 95th centile: 124/76 mmHg), and
urinalysis (normal sediment, albumin/creatinine 3.5 g/mol) were
normal. No further family members were suffering from HUS or
renal disease.
Case 2
A 3-year-old boy presented with a 5-day history of pallor and
several blue bruises. A week earlier he had suffered from watery
diarrhea for 2 days after the consumption of raw cow milk. Physical
examination demonstrated high blood pressure (120/66 mmHg:
95th centile: 109/65 mmHg), mild scleral jaundice and swollen
eyelids. Hematology revealed anemia (hemoglobin 59 g/l) and
thrombocytopenia (123109/l); a blood film showed marked red
blood cell fragmentation. Blood chemistry disclosed mild renal
failure (creatinine 103 mol/l, normal range for age <51 mol/l;
urea 14 mmol/l), hyperbilirubinemia (53 mol/l) and high lactate
dehydrogenase (1,034 U/l). Complement C3 was normal, antinu-
clear or antineutrophil cytoplasmic autoantibodies were not
detected and the direct Coombs test was negative. Specific E. coli
antibodies were not measured. Urinalysis revealed hematuria, red
cell casts and marked proteinuria. E. coli strains harboring genes for
shigatoxin could not be cultured from his stool at this stage.
Systolic blood pressure further increased up to 140–160 mmHg,
requiring intravenous administration of dihydralazine. Several
packed red cells had to be given due to persistent microangiopathic
hemolytic anemia. A renal biopsy disclosed extensive lesions of
thrombotic microangiopathy including both intraglomerular capil-
laries and extraglomerular arterioles and small arteries. Urinary
output decreased and the boy became anuric. Despite the unusual
course—slow progression of renal failure over 3 weeks—a
presumptive diagnosis of diarrhea-positive HUS was made.
Hemodialysis had to be started 18 days after admission. In
addition, plasma exchange with albumin and an infusion of fresh
frozen plasma at the end of each session was applied on 12
occasions. As renal function did not improve, plasma exchange was
stopped and the patient switched to automated peritoneal dialysis
(duration: 12 h during the night; filling volume: 40 ml/kg body
weight: number of exchanges: 12/night). Blood pressure control
was only achieved with a triple therapy of atenolol, nifedipine and
minoxidil.
After being on a constant peritoneal dialysis regimen for
14 months, the boy started to pass urine. Firstly, there were only
small volumes once a week, but urine output increased steadily.
Finally, 16 months after onset of renal replacement therapy,
peritoneal dialysis was ceased.
Recently, i.e., 5 years after cessation of dialysis, the boy was in
good health. Growth (body weight: 28 kg, height: 1.31 m) and
cognitive development were both normal. Renal function, as
assessed as plasma creatinine (90 mol/l, normal range for age
<75 mol/l) and estimated glomerular filtration rate (Schwartz
formula: 58 ml/min/1.73 m2 body surface area), was slightly
reduced. There was mild microhematuria, but no proteinuria.
Despite antihypertensive treatment with valsartane and amlodipine
(20 and 7.5 mg daily, respectively), blood pressure (casual: 127/
83 mmHg; 24-h ambulatory: 128/83 mmHg) remained persistently
above the 95th centile (casual: 116/77; 24-h: 117/75). Echocardi-
ography and fundoscopy were normal. No further family members
were suffering from HUS or renal disease.
Discussion
We report long-lasting recovery of renal function after
prolonged dialysis, i.e., more than 6 months, in pediatric
hemolytic uremic syndrome. The term end-stage kidney
disease denotes irreversible deterioration of renal func-
tion. A few patients, mainly adults, have been reported to
regain independent renal function of their native kidneys
after long-term dialysis [1, 2, 3, 4, 5, 7, 8, 9]. Recovery
mostly occurred within 6–12 months of initiating renal
replacement therapy and was generally partial, both
related to glomerular and tubular function. In addition,
recovery appeared to be more common in kidney diseases
secondary to treatable malignancies, adverse effects of
drugs as reported in two cases of atypical HUS [2, 4] or in
hypertensive kidney disease [1, 9].
Recovery after long-term dialysis has occasionally
been reported in children [6, 10]: The duration of renal
replacement therapy had lasted less than 1 year in the
majority of these children. In addition, the recovery was
transient and lasted less than 1 year in the majority of
patients.
Which protective factors might have contributed to the
favorable outcome in our patients with HUS are not clear,
especially as two main risk factors of bad outcome in
HUS [12]—long-term anuria in both patients and exten-
sive thrombotic microangiopathy in one—were present.
In particular, atypical HUS carries a substantial risk for
end-stage renal failure and is an important cause of end-
stage renal failure in childhood [11]. The high risk of
recurrence—associated with high morbidity and mortal-
ity—has prompted some centers, including our own, to
avoid early renal transplantation in those children.
In conclusion the present report suggests that caution is
appropriate before offering early renal transplantation to
pediatric patients with presumed end-stage kidney disease
secondary to diarrhea-associated or atypical HUS.
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